Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis

被引：55
|
作者：
Jung, P. [1 ]
Beyerle, A. [1 ]
Ziemann, U. [1 ]
机构：
[1] Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷 / 04期
关键词：
evoked potentials; clinical disease progression; ipsilateral silent period; multiple sclerosis functional composite;
D O I：
10.1177/1352458507085758
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In 37 patients with early relapsing-remitting multiple sclerosis (RRMS), a multimodal EP score (mEPS) and clinical scores (Expanded Disability Status Scale (EDSS) and multiple sclerosis functional composite (MSFC) were obtained prospectively over 24 months. Changes in mEPS correlated with changes in EDSS (Spearman's p = 0.69, p < 0.0001) and MSFC (p = -0.41, p < 0.02). Patients with relevant EDSS progression (n = 7) showed stronger mEPS deterioration than clinically stable patients (10.8 +/- 3.2 versus 1.3 +/- 0.8, p < 0.005). Baseline mEPS was not significantly correlated with baseline EDSS but with EDSS after 24 months (p = 0.39, p < 0.02). The data suggest that serial mEPS measure and moderately predict clinically relevant disease activity in the therapeutically most relevant early stage of RRMS.
引用
收藏
页码：553 / 556
页数：4
相关论文
共 50 条
  • [21] Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis
    OConnor, P
    Marchetti, P
    Perera, M
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (03) : M123 - M123
  • [22] Sensitivity of tibial somatosensory evoked potentials in diagnosing patients with relapsing-remitting form of multiple sclerosis
    Djuric, V.
    Milosevic, V.
    Ljubisavljevic, S.
    Stamenovic, J.
    Djordjevic, G.
    Prazic, A.
    [J]. JOURNAL OF NEUROLOGY, 2011, 258 : 123 - 123
  • [23] Evoked potential abnormality scores are a useful measure of disease burden in relapsing-remitting multiple sclerosis
    O'Connor, P
    Marchetti, P
    Lee, L
    Perera, M
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 404 - 407
  • [24] Cognitive deficits in early relapsing-remitting multiple sclerosis
    Tinnefeld, M.
    Wilhelm, H.
    Daum, I.
    Faustmann, P. M.
    Haase, C. G.
    [J]. AKTUELLE NEUROLOGIE, 2008, 35 (01) : 2 - 7
  • [25] Early treatment can postpone the time to disability pension in relapsing-remitting multiple sclerosis
    Wandall-Holm, M.
    Kopp, T. Iskov
    Buron, M. Due
    Sellebjerg, F.
    Magyari, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 63 - 63
  • [26] Early Treatment Can Postpone the Time to Disability Pension in Relapsing-Remitting Multiple Sclerosis
    Wandall-Holm, Malthe
    Buron, Mathias
    Kopp, Tine Iskov
    Sellebjerg, Finn
    Magyari, Melinda
    [J]. NEUROLOGY, 2022, 98 (18)
  • [27] The effects of immunomodulatory treatments on the progression of relapsing-remitting multiple sclerosis
    Candan, E
    Yilmaz, Z
    Canturk, IA
    Isik, N
    Yildiz, N
    Seleker, T
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S234 - S235
  • [28] Impact of beta-interferon on disability progression in relapsing-remitting multiple sclerosis: a Bayesian analysis
    O'Rourke, K.
    Walsh, C.
    Hutchinson, M.
    [J]. JOURNAL OF NEUROLOGY, 2006, 253 : 102 - 103
  • [29] Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
    Lavery, Amy M.
    Verhey, Leonard H.
    Waldman, Amy T.
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014
  • [30] Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis
    Shirani, Afsaneh
    Zhao, Yinshan
    Karim, Mohammad Ehsanul
    Evans, Charity
    Kingwell, Elaine
    van der Kop, Mia L.
    Oger, Joel
    Gustafson, Paul
    Petkau, John
    Tremlett, Helen
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (03): : 247 - 256
12345